Akt in prostate cancer: possible role in androgen-independence

Paramita M Ghosh1, Shazli Malik, Roble Bedolla

  • 1Department of Surgery, University of Texas Health Science Center at San Antonio and South Texas Veterans Health Care System, Audie L. Murphy Veterans Administration Hospital, San Antonio, TX 78229-3900, USA.

Current Drug Metabolism
|December 20, 2003
PubMed

Insights

Activated Akt (a protein kinase) promotes prostate cancer progression to an androgen-independent state. This occurs through modulation of the androgen receptor (AR), impacting tumor cell survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Akt, a key downstream effector of PI3K, is frequently implicated in prostate cancer.
  • Akt activation is crucial for prostate cancer progression toward androgen independence.

Purpose of the Study:

  • To investigate the role of Akt activation in prostate cancer progression.
  • To explore the mechanism by which Akt promotes androgen-independent survival of prostate tumor cells.

Main Methods:

  • Analysis of Akt expression and phosphorylation in human prostate cancer tissues.
  • Comparison of Akt activation in normal tissue, PIN, and various grades of prostate cancer.
  • Investigation of the relationship between Akt phosphorylation and ERK inactivation.

Main Results:

  • No Akt gene amplification or increased total protein expression in prostate cancer versus normal tissue.
  • Significantly increased phosphorylated (activated) Akt in poorly differentiated tumors compared to normal tissue, PIN, and well-differentiated cancers.
  • Akt phosphorylation correlated with ERK inactivation.

Conclusions:

  • Akt activation, not increased expression, is associated with advanced prostate cancer.
  • Akt may promote androgen-independent prostate cancer cell survival by modulating androgen receptor (AR) expression and activation.

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...